SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank0
3Y CAGR-7.2%
5Y CAGR-12.5%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-7.2%/yr
Annual compound
5Y CAGR
-12.5%/yr
Recent acceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $240664.00 | -24.4% |
| 2024 | $318401.00 | +1.0% |
| 2023 | $315284.00 | +4.5% |
| 2022 | $301584.00 | +2.4% |
| 2021 | $294459.00 | -37.2% |
| 2020 | $469151.00 | +9.5% |
| 2019 | $428476.00 | - |